Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Texts from your doctor could help prevent diabetes

NCT ID NCT04773834

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 36 times

Summary

This study tested whether automated messages from doctors could keep people with prediabetes engaged in a digital diabetes prevention program. Over 550 participants used the Noom app along with a fitness tracker and scale, and some received tailored text or MyChart messages based on their activity. The goal was to see if these nudges could help people lose weight, lower blood sugar, and prevent type 2 diabetes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRE-DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • NYU Langone Health

    New York, New York, 10016, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

automated text and MyChart messages tailored to patient engagement levels

What this could lead to

If it works, this could offer a low-cost way to help people with prediabetes stay engaged in prevention programs and lower their risk of developing diabetes.

What could go wrong

This is a completed study with 551 participants, but the intervention is just messaging—it may not be enough to cause lasting behavior change or improve health outcomes.

Conditions

The condition(s) this trial relates to.

glucose intolerance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.